Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older
- PMID: 36189170
- PMCID: PMC9510438
- DOI: 10.1002/deo2.167
Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older
Abstract
Objectives: Chemoradiotherapy (CRT) or radiotherapy (RT) alone is often the treatment of choice for elderly patients with esophageal cancer with the expectation of organ preservation. However, salvage treatment remains a problem when endoscopic resection is not indicated for local failure after CRT/RT. Photodynamic therapy (PDT) is indicated for local failure after CRT/RT, but there are few reports on its efficacy and safety in elderly patients. This study aimed to assess the outcome of PDT for local failure after CRT/RT for esophageal cancer in elderly patients.
Methods: This retrospective single-center study included 42 patients who first underwent PDT between April 2013 and June 2021. Patients aged ≥80 and <80 years were classified into the elderly and nonelderly groups, respectively. Local complete response rate, overall survival, progression-free survival, and incidence of adverse events related to PDT were compared retrospectively between the groups.
Results: The local complete response rate was 93.3% in the elderly group and 85.7 in the non-elderly group. The 2-year overall survival rate was 68.6% and 72.5%, and the 2-year progression-free survival rate was 49.5% and 70.0% in the elderly and nonelderly groups, respectively. There was no significant difference in any of these outcomes between the groups. In terms of adverse events, pneumonia and delirium tended to occur more frequently in the elderly group, but there were no serious adverse events in either group.
Conclusion: The outcome of salvage PDT in the local control was comparable between the elderly and nonelderly patients for local failure after CRT/RT for esophageal cancer.
Keywords: aged; chemoradiotherapy; esophageal neoplasms; photochemotherapy; salvage therapy.
© 2022 The Authors. DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.
Conflict of interest statement
None.
Figures




Similar articles
-
Advantages of salvage photodynamic therapy using talaporfin sodium for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.Surg Endosc. 2020 Feb;34(2):899-906. doi: 10.1007/s00464-019-06846-3. Epub 2019 May 28. Surg Endosc. 2020. PMID: 31139985
-
A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.Oncotarget. 2017 Mar 28;8(13):22135-22144. doi: 10.18632/oncotarget.14029. Oncotarget. 2017. PMID: 28212527 Free PMC article. Clinical Trial.
-
Association of local complete response with prognosis after salvage photodynamic therapy for esophageal squamous cell carcinoma.Dig Endosc. 2021 Mar;33(3):355-363. doi: 10.1111/den.13730. Epub 2020 Jul 17. Dig Endosc. 2021. PMID: 32434267
-
Role of photodynamic therapy in the treatment of esophageal cancer.Dig Endosc. 2019 Sep;31(5):508-516. doi: 10.1111/den.13353. Epub 2019 Mar 5. Dig Endosc. 2019. PMID: 30667112 Review.
-
Endoscopic management of esophageal cancer after definitive chemoradiotherapy.Dig Dis Sci. 2013 Jun;58(6):1477-85. doi: 10.1007/s10620-012-2554-0. Epub 2013 Jan 17. Dig Dis Sci. 2013. PMID: 23325163 Review.
Cited by
-
Predictive Factors for the Efficacy of Head and Neck Photoimmunotherapy and Optimization of Treatment Schedules.Cancer Diagn Progn. 2025 Mar 3;5(2):179-188. doi: 10.21873/cdp.10428. eCollection 2025 Mar-Apr. Cancer Diagn Progn. 2025. PMID: 40034957 Free PMC article.
-
Evaluation of the efficacy and safety of salvage photodynamic therapy with talaporfin sodium for lesions beyond those indicated for investigator-initiated clinical trials.Esophagus. 2025 Jun 15. doi: 10.1007/s10388-025-01134-7. Online ahead of print. Esophagus. 2025. PMID: 40517344
-
The Prognostic Factors of Bloodstream Infection in Immunosuppressed Elderly Patients: A Retrospective, Single-center, Five-year Cohort Study.Clin Interv Aging. 2022 Nov 18;17:1647-1656. doi: 10.2147/CIA.S386922. eCollection 2022. Clin Interv Aging. 2022. PMID: 36425478 Free PMC article.
-
Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy.Life (Basel). 2023 May 29;13(6):1276. doi: 10.3390/life13061276. Life (Basel). 2023. PMID: 37374059 Free PMC article.
References
-
- World Health Organization . Oesophagus cancer fact sheet [Internet]. World Health Organization, International Agency for Research on Cancer, GLOBOCAN; 2020 [Cited 2022 May 20]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/6‐Oesophagus‐fact‐shee....
-
- Herskovic A, Martz K, al‐Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593–8. - PubMed
-
- Hironaka S, Ohtsu A, Boku N et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3)N(any)M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003; 57: 425–33. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous